Down syndrome is characterized by multiple phenotypic manifestations associated with trisomy of chromosome 21. The transient myeloproliferative disorder and acute megakaryocytic leukemia associated with Down syndrome are uniquely associated with mutations in the transcription factor GATA1; however, the identity of trisomic genes on chromosome 21 that predispose to these hematologic disorders remains unknown. 
Introduction
Down syndrome (DS) is uniquely associated with a transient myeloproliferative disorder (DS-TMD) and acute megakaryocytic leukemia (DS-AMKL). 1 Increased dosage of genes within chromosome 21 (Hsa21), including AML1/RUNX1, ETS2, and ERG, has been postulated to cooperate with an acquired GATA1 mutation to generate DS-TMD and DS-AMKL, 2 although direct evidence identifying critical genes is lacking.
A member of the ETS family of transcription factors, 3 ERG is necessary for normal platelet development and stem cell function 4 and has been implicated in the pathogenesis of human leukemia. [5] [6] [7] Located on the long arm of Hsa21, 8 evidence for a role of ERG in the development of human DS-TMD and DS-AMKL arose from detection of ERG expression in human acute megakaryoblastic leukemia cell lines and primary human samples of DS-AMKL and DS-TMD. 2 In vitro, overexpression of ERG can induce megakaryocytic differentiation of human cell lines and murine fetal liver progenitors, 4,9,10 and can interact with GATA1 mutations to immortalize fetal liver progenitors. 9, 10 The Ts(17 16 )65Dn mouse is a well-characterized model of DS containing a trisomic chromosomal Down syndrome critical region (DSCR) syntenic to Hsa21, including 94 orthologs of the 170 genes within Hsa21. 11 Ts(17 16 )65Dn mice develop a highly penetrant myeloproliferative disorder (MPD), 12 supporting the contention that trisomy of critical gene(s) within Hsa21 can lead to hyperproliferation and megakaryocytic differentiation, and may therefore predispose to the development and phenotype of the megakaryoblasts observed with human DS-TMD and DS-AMKL.
To determine whether trisomy of functional Erg drives the development of the myeloproliferative phenotype observed in Ts(17 16 )65Dn mice, trisomic Ts(17 16 )65Dn mice were crossed to mice carrying the loss-of-function Erg mld2 mutation that contains a S329P nontransactivating missense mutation in the DNA-binding region of Erg, 4 to generate mice disomic for functional Erg but trisomic for all other genes within the DSCR of Ts(17 16 )65Dn.
Methods

Mice
Derivation and genotyping of the Erg mld2 mutant allele has been described. 4 Ts(17 16 )65Dn mice (The Jackson Laboratory) were maintained on an F1 background of C57BL/6JEiJ and C3HHeSnJ. All mice were derived from the first-generation progeny of matings between Erg ϩ/mld2 and Ts(17 16 )65Dn mice. Genotyping for segmental trisomy of chromosome 16 was performed using the MLPA Reaction Kit (MRC Holland). 13 
Hematology and histology
Blood was collected into tubes containing ethylenediaminetetraacetic acid (Becton Dickinson) and analyzed with an Advia 120 analyzer (Bayer). Singlecell suspensions from 1 femur and spleen were collected in balanced salts solution (0.15M NaCl, 4mM KCl, 2mM CaCl 2 , 1mM MgSO 4 , 1mM KH 2 PO 4 , 0.8mM K 2 HPO 4 , and 15mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid supplemented with 2% [vol/vol] bovine calf serum). Bone marrow cells (2.5 ϫ 10 4 ) were cultured in 1-mL volumes of 0.3% agar in Iscove modified Dulbecco medium containing 20% newborn calf serum and stem cell factor (50 ng/mL), erythropoietin (2 U/mL), and interleukin-3 (10 ng/mL), incubated An Inside Blood analysis of this article appears at the front of this issue.
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The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked ''advertisement'' in accordance with 18 USC section 1734. For personal use only. on September 13, 2017. by guest www.bloodjournal.org From for 7 days in a fully humidified atmosphere of 5% CO 2 in air, fixed, dried onto glass slides, and stained for acetylcholinesterase, Luxol fast blue, and hematoxylin, and the number and type of colonies were determined. Organs were fixed in 10% buffered formalin and embedded in paraffin, and 1-to 3-m sections were stained with hematoxylin and eosin or silver nitrate for reticulin visualization. Megakaryocytes were enumerated by microscopic examination of bone marrow and spleen sections. Megakaryocyte ploidy analyses were performed as described. 14 
Flow cytometry
Lineage Ϫ c-Kit ϩ Sca1 ϩ (LSK) staining used biotinylated anti-TER119, anti-GR1, anti-Mac1, anti-B220, anti-CD4, and anti-CD8 antibodies (BD Pharmingen), in addition to anti-c-Kit-allophycocyanin and anti-Sca1-phycoerythrin-cyanine 7 (eBioscience) with secondary staining using streptavidin peridinin-chlorophyll-protein complex-cyanine 5.5 (BD Pharmingen). Mature lineage staining used fluorochrome-conjugated anti-TER119, anti-CD41, anti-GR1, anti-MAC1, anti-B220, anti-CD4, and anti-CD8 antibodies (BD Pharmingen).
Statistical analysis
Student unpaired 2-tailed t tests with Holm modification of Bonferroni correction for multiple testing 15 were used.
Results and discussion
To determine the specific contribution of trisomy of the Erg gene in the myeloproliferative phenotype associated with Down syndrome, mice disomic for functional Erg but otherwise trisomic on the Ts(17 16 )65Dn background were analyzed. As previously described, at 12 months of age trisomic Ts(17 16 )65Dn mice (hereafter referred to as Ts65Dn/Erg ϩ/ϩ/ϩ ) demonstrated progressive thrombocytosis ( Figure 1A) , megakaryocytosis ( Figure 1B) , and megakaryocytic dysplasia within the bone marrow ( Figure 1C ), extramedullary hematopoiesis in the spleen with disrupted splenic architecture, expansion of the red pulp, and focal areas of myelopoiesis with prominent megakaryocytosis (supplemental Figure 1 , available on the Blood Web site; see the Supplemental Materials link at the top of the online article). Trisomic Ts(17 16 )65Dn mice, with only 2 functional alleles of Erg (Ts65Dn/Erg ϩ/ϩ/mld2 ), demonstrated amelioration of the histopathologic myeloproliferative features that were evident in trisomic littermates, with correction of thrombocytosis, bone marrow megakaryocytosis, and extramedullary hematopoiesis to levels observed in wild-type disomic littermate controls (Erg ϩ/ϩ , Figure 1 ). Significant reticulin fibrosis of the bone marrow was noted in 3 of 9 Ts65Dn/Erg ϩ/ϩ/ϩ mice analyzed at 12 months, but not in other genotypes.
Alterations in the numbers of hematopoietic stem and progenitor cells that characterize the myeloproliferative phenotype in trisomic mice were also corrected when trisomy at the Erg locus was reduced to functional disomy. The expanded bone marrow Lin Ϫ c-Kit ϩ Sca1 ϩ (LSK) compartment observed in trisomic Ts65Dn/Erg ϩ/ϩ/ϩ mice returned to normal levels observed in disomic littermate controls in the Ts65Dn/Erg ϩ/ϩ/mld2 mice ( Figure 2A ). Clonogenic culture assays assessing bone marrow and spleen hematopoietic progenitor cell frequency using stimulation with a cytokine cocktail of stem cell factor, interleukin-3, and erythropoietin demonstrated that increased preprogenitor blast colony 16 and total colony frequency from Ts65Dn/Erg ϩ/ϩ/ϩ bone marrow were both corrected to disomic littermate control frequencies in the Ts65Dn/Erg ϩ/ϩmld2 mice Figure 1 . Hematologic analysis. (A) Peripheral blood platelet counts. Means with SDs are shown for Ts65Dn/Erg ϩ/ϩ/ϩ (OE, n ϭ 9), Ts65Dn/Erg ϩ/ϩ/mld2 (ƒ, n ϭ 5), Erg ϩ/ϩ (F, n ϭ 6), and Erg ϩ/mld2 (E, n ϭ 8). P values from unpaired 2-tailed t tests of data from 12-month-old mice: *P ϭ .008 for comparison of data from Ts65Dn/Erg ϩ/ϩ/ϩ and Ts65Dn/Erg ϩ/ϩ/mld2 ; P ϭ .002 for comparison of Ts65Dn/Erg ϩ/ϩ/ϩ and Erg ϩ/ϩ ; and P ϭ .064 for comparison of Ts65Dn/Erg ϩ/ϩ/mld2 and Erg ϩ/ϩ . (B) Megakaryocyte counts per high-power field (ϫ200) of bone marrow and spleen histologic sections taken from 12-month-old mice. Means with standard deviations are shown. P values indicated are from unpaired 2-tailed t tests. Erg ϩ/ϩ (n ϭ 6), Erg ϩ/mld2 (n ϭ 8), Ts65Dn/Erg ϩ/ϩ/ϩ (n ϭ 9), and Ts65Dn/Erg ϩ/ϩ/mld2 (n ϭ 5). (C) Hematoxylin and eosin staining of representative bone marrow sections at ϫ400 magnification (Zeiss Axioplan-2 microscope, 40ϫ/0.75 NA objective with AxioCam Hrc and AxioVision Version 3.1 image-acquisition software). Figure 2B ). Consistent with a multilineage myeloproliferative phenotype in trisomic mice, flow cytometric analysis of mature hematopoietic lineages from bone marrow suspensions showed an increased proportion of granulocytes and megakaryocytes in Ts65Dn/Erg ϩ/ϩ/ϩ mice whereas proportions in Ts65Dn/Erg ϩ/ϩ/mld2 mice were similar to those in control Erg ϩ/ϩ mice (supplemental Figure 2) . There was no difference in megakaryocyte ploidy between the different genotypes (supplemental Figure 3) .
TRISOMY of
Thus, using the loss-of-function Erg mld2 allele to return the functional Erg gene dosage to disomy, while maintaining trisomy of other genes, including AML1/Runx1 and Ets2 in the DSCR, we directly implicate Erg in myeloproliferative disease pathogenesis in trisomic Ts(17 16 )65Dn mice. Notably, despite the presence of Erg in the trisomic interval of the Ts1Cje DS model, these mice do not develop MPD, which may be ascribable to the effect of strain-specific genetic background and potential interaction of other genes in the Ts65Dn segmental trisomy that are not contained in the Ts1Cje segment. 17, 18 Whereas the MPD in Ts65Dn mice occurs in the absence of GATA1 mutations, which are characteristic of disease in humans, acute myeloproliferation and megakaryocytic differentiation are key pathologic features of hematologic disease associated with DS. In addition, the critical chromosomal region in human DS-AMKL/ DS-TMD has been localized to an 8.3-Mb segment of Hsa21 containing the ERG gene. 19 Our genetic evidence establishing the need for Erg trisomy for such pathology in Ts(17 16 )65Dn mice implies that ERG may also be a critical gene in human trisomy 21, playing a fundamental role in the pathogenesis of DS-TMD and DS-AMKL in human DS. The total femoral cellularity was the same for mice of all genotypes with Erg ϩ/ϩ (n ϭ 6), Erg ϩ/mld2 (n ϭ 8), Ts65Dn/Erg ϩ/ϩ/ϩ (n ϭ 9), and Ts65Dn/ Erg ϩ/ϩ/mld2 (n ϭ 5). P values from unpaired 2-tailed t tests: P ϭ .038 for comparison of data from Ts65Dn/Erg ϩ/ϩ/ϩ and Ts65Dn/Erg ϩ/ϩ/mld2 ; P ϭ .048 for comparison of Ts65Dn/Erg ϩ/ϩ/ϩ and Erg ϩ/ϩ ; and P ϭ .57 for comparison of Ts65Dn/Erg ϩ/ϩ/mld2 and Erg ϩ/ϩ . (B) Hematopoietic progenitor cell numbers from agar colony assays of 25 000 bone marrow cells stimulated with stem cell factor, interleukin-3, and erythropoietin for 7 days, with mean and SD of the number of blast colonies and total colonies shown. Erg ϩ/ϩ (n ϭ 6), Erg ϩ/mld2 (n ϭ 8), Ts65Dn/ Erg ϩ/ϩ/ϩ (n ϭ 9), and Ts65Dn/Erg ϩ/ϩ/mld2 (n ϭ 5). P values indicated are from unpaired 2-tailed t tests.
